Interpace Biosciences issues $2M convertible note to BroadOak; conversion tied to PIPE of >=$10M

INTERPACE BIOSCIENCES, INC.

$2M principal, 9% annual interest, unsecured, interest-only until Aug 5, 2022 maturity date.
Converts into common stock automatically if PIPE closing of at least $10M net proceeds occurs by maturity.
If PIPE not closed by Aug 5, 2022, converts into additional term loan under existing BroadOak subordinated facility.
Comerica Bank consented; note is subordinated to Comerica's senior secured debt.
Proceeds used for general corporate purposes and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.